FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

423 letters match. Newest first.

  1. CARsgen Therapeutics Corporation

    FDA warns CARsgen over CGMP violations for investigational CAR T cell products at Durham facility.

    High risk
  2. Eugia Pharma Specialities Limited

    FDA cited Eugia Pharma Specialities for CGMP violations at its India sterile injectable plant, including falsified records and contamination risks.

    High risk
  3. Manabi Export Panama S.A.

    FDA cited Panama seafood processor Manabi Export for missing HACCP (food-safety plan) controls on ready-to-eat cooked clam meat in reduced-oxygen packaging.

    High risk
  4. Agustson A/S

    Agustson A/S's frozen hot smoked trout fillet plan has serious seafood safety gaps, FDA says.

    High risk
  5. Konrad Rejdak, M.D., Ph.D.

    FDA warns Dr. Konrad Rejdak over clinical trial data integrity failures in a CIDP immune globulin study.

    Medium
  6. High Quality Organics, Inc.

    FDA warned High Quality Organics over ready-to-eat spices after finding weak pathogen controls and no pesticide-hazard reanalysis.

    High risk
  7. Corporacion Avicola Morovis Inc

    FDA warns Corporacion Avicola Morovis over Salmonella prevention failures at its Puerto Rico shell egg farm.

    High risk
  8. Brassica Pharma Pvt. Ltd.

    FDA warns Brassica Pharma over fabricated sterility and environmental data and poor aseptic controls for sterile drugs.

    High risk
  9. Discover Fresh Foods, LLC

    FDA found Listeria monocytogenes in Discover Fresh Foods' Easley, SC plant, where refrigerated ready-to-eat dips are made under insanitary conditions.

    High risk
  10. Donggang Wanrui Food Co., Ltd.

    Donggang Wanrui Food Co., Ltd. lacked required seafood safety plan monitoring and records for raw frozen octopus and crab.

    High risk
  11. Massachusetts Institute of Technology MIT

    FDA says MIT's review board for human research failed to make sure consent forms and meeting records met federal rules.

    Medium
  12. Dalian Lingfa Food Co., Ltd.

    Dalian Lingfa Food did not control Clostridium botulinum risk in vacuum-packed ready-to-eat bamboo shoots, FDA says.

    High risk
  13. Sakhon Wattana Thang Chue Hah

    FDA warns Thai fish sauce maker Sakhon Wattana Thang Chue Hah over missing safety controls for pathogens and histamine.

    High risk
  14. Optikem International Inc.

    FDA warns Optikem International after inspection found inadequate aseptic controls for sterile ophthalmic drugs, including contamination and validation failures.

    High risk
  15. PepsiCo, Inc.

    FDA warned PepsiCo after Salmonella Cubana was found at its Danville, Illinois Quaker Oats plant, prompting recalls of granola bars and cereals.

    High risk
  16. Tamara Fruit CJSC

    FDA warns Tamara Fruit CJSC that its juice nectars and acidified Imam-Bayaldi are adulterated after inspection found HACCP and recordkeeping failures.

    High risk
  17. Sani-Care Salon Products, Inc.

    FDA warns Sani-Care Salon Products over CGMP failures in hand sanitizer manufacturing, including inadequate quality oversight and testing.

    High risk
  18. GFA Production Xiamen Co., Ltd.

    GFA Production Xiamen failed CGMP for drugs, including process validation, cleaning, and lab controls.

    High risk
  19. Neobiosis, LLC

    FDA warns Neobiosis over unapproved amniotic fluid and umbilical cord products and serious manufacturing quality failures.

    High risk
  20. Chang and Son Enterprises, Inc.

    FDA found Listeria monocytogenes in Chang and Son's mung bean and soybean sprout operation and in its sprouts.

    High risk
  21. McClure’s Lancaster Old Fashioned, LLC

    FDA: McClure's Lancaster Old Fashioned lacked hazard analysis; ready-to-eat sticky buns, pies and cakes made under insanitary conditions.

    High risk
  22. Safari Stem Cell, LLC

    FDA warned Safari Stem Cell for selling unapproved stem cell animal drugs made without required CGMP controls, including sterility testing.

    High risk
  23. Akan Biosciences, Inc.

    FDA warned Akan Biosciences over unapproved Ayama injectable and donor-screening failures.

    High risk
  24. Central Admixture Pharmacy Services, Inc.

    FDA warned sterile drug compounder Central Admixture Pharmacy Services (Phoenix) that dirty areas and weak sterility testing made its drugs adulterated.

    High risk
  25. Ogura Shokuhin Co. Ltd.

    Ogura Shokuhin’s dried fish products lacked a required seafood safety plan and had unsafe color and labeling violations.

    High risk
  26. California Bread Co.

    FDA warns California Bread Co. (Chula Vista, CA) that its bread had undeclared milk and Yellow No. 5 and misbranded labels.

    High risk
  27. Ng Zheng Inc. DBA Kwan Sang Noodle Company

    FDA warns Denver noodle maker over allergen, pathogen, pest and sanitation failures and missing food facility registration.

    High risk
  28. Blue Caribbean Foods Inc.

    FDA warns Blue Caribbean Foods after inspection found its fresh tuna HACCP plan and records inadequate.

    High risk
  29. Ocean Group Inc.

    Ocean Group Inc.'s ready-to-eat salmon and tuna were tied to Listeria monocytogenes and insanitary conditions after an FDA inspection.

    High risk
  30. Hacienda Mexican Foods, LLC

    FDA warns Hacienda Mexican Foods of Salmonella risk and missing controls in ready-to-eat tortillas.

    High risk
  31. Central Admixture Pharmacy Services, Inc.

    FDA warned Central Admixture Pharmacy Services' Allentown outsourcing facility over sterile drug contamination and CGMP failures.

    High risk
  32. JX Restaurants, Inc.

    FDA warns JX Restaurants after Listeria was found in its ready-to-eat rice and noodle meal plant.

    High risk
  33. Kevin R. Bender, M.D./DBC Research Corporation

    Clinical investigator Kevin R. Bender failed to secure a controlled investigational drug, and 110 kits were stolen.

    High risk
  34. Mariscos Perla Mar S. de R.L.

    FDA found Mariscos Perla Mar's seafood safety plans missing Clostridium botulinum controls and sanitation records incomplete for frozen lobster and conch.

    High risk
  35. Sheng Kee of California, Inc dba Sheng Kee Bakery

    Sheng Kee Bakery cited for insanitary conditions, missing food safety plan, undeclared egg and color additive in bakery products.

    High risk
  36. Pingdingshan Tianjing Plant Albumen Co., Ltd.

    FDA cited Pingdingshan Tianjing Plant Albumen, a Chinese maker of ready-to-eat soy protein isolate, for insanitary conditions and unsupported test results on certificates.

    High risk
  37. Bioptimal International

    Bioptimal International made unapproved changes to heart catheters and lacked quality and reporting controls.

    High risk
  38. Jolca, S.A.

    FDA warned Jolca S.A. that its seafood-stuffed green olives lacked required HACCP controls for histamine, S. aureus toxin, and allergens.

    High risk
  39. Korean Food, Inc.

    FDA inspected Korean Food, Inc.'s Texas sprout and kimchi facility and found Listeria monitoring gaps, insanitary conditions, and misbranded kimchi labels.

    High risk
  40. Euro USA Inc

    Euro USA Inc’s seafood HACCP plans had inadequate temperature limits, monitoring, and corrective actions.

    High risk
  41. Kilitch Healthcare India Limited

    FDA warns Kilitch Healthcare India over insanitary sterile drug manufacturing and falsified environmental monitoring data.

    High risk
  42. Zoet Poultry, Inc.

    Zoet Poultry's shell egg farm lacked an implemented Salmonella Enteritidis prevention plan and required environmental testing.

    High risk
  43. Bret R. Rutherford, M.D.

    FDA warned Dr. Bret R. Rutherford for enrolling ineligible patients in two drug studies by skipping required antidepressant washout.

    High risk
  44. New York State Psychiatric Institute IRB

    FDA warned New York State Psychiatric Institute's review board it failed to report serious research problems and reviewed drug studies without required nonscientific member.

    High risk
  45. F1 Foods Inc. D/B/A Flavor First Foods Inc.

    F1 Foods Inc. d/b/a Flavor First Foods was cited for insanitary conditions and food-safety control failures at its ready-to-eat foods facility.

    High risk
  46. ReNovo, Inc. DBA Provision Device Reprocessing Solutions

    ReNovo, a device reprocessor in Bend, Oregon, sold new device models without required FDA clearances and had quality system failures.

    High risk
  47. Boehringer Ingelheim Animal Health USA

    FDA warned Boehringer Ingelheim Animal Health USA that Senvelgo promotional materials falsely claimed safety and effectiveness in previously insulin-treated cats.

    High risk
  48. Nobles Medical Technology II, Inc.

    FDA warns Nobles Medical Technology II over oversight failures in NobleStitch EL clinical study.

    High risk
  49. Trang Thuy Seafood Co., LTD

    FDA found Trang Thuy Seafood's tuna HACCP plan did not control histamine formation after a histamine poisoning recall.

    High risk
  50. Amman Pharmaceutical Industries

    FDA warned Amman Pharmaceutical Industries after a 2023 inspection found sterile drug manufacturing and data integrity failures.

    High risk